Creating vaccines for enteroviruses and rhinoviruses
Design and testing picornavirus vaccine candidates
This study is working on a fast way to create vaccines that can help protect kids from common viruses that cause colds and stomach bugs, making sure they can quickly adapt to new strains to keep everyone safe and healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10863659 on NIH RePORTER |
What this research studies
This research focuses on developing a rapid vaccine platform to combat enteroviruses and rhinoviruses, which are significant causes of respiratory and gastrointestinal diseases, especially in children. The approach involves designing immunogens that target vulnerable sites on these viruses, utilizing advanced techniques in molecular biology and immunology. By adapting quickly to emerging strains, the project aims to enhance vaccine efficacy and accessibility, ultimately protecting populations from these viral threats.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are children under the age of 11 who are at risk for infections caused by enteroviruses and rhinoviruses.
Not a fit: Patients who are older than 11 years or those who do not have a history of infections related to these viruses may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the incidence of serious viral infections in children.
How similar studies have performed: Previous research has shown promise in developing vaccines for similar viral infections, indicating that this approach has the potential for success.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Andino, Raul — Vanderbilt University Medical Center
- Study coordinator: Andino, Raul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.